CMB increased its holdings of Sino Biopharmaceutical Limited (01801.HK) by approximately 255,050 shares at a price of approximately 80.68 Hong Kong dollars per share.

According to the Wisdom Finance APP, the latest information from the Hong Kong Stock Exchange shows that on October 30th, Morgan Stanley increased its holdings in Sino Biopharmaceutical (01801.HK) by 2.550546 million shares, with a price of 80.6819 Hong Kong dollars per share, for a total amount of approximately 206 million Hong Kong dollars. After the increase, the latest number of shares held is approximately 87.0232 million shares, and the latest shareholding ratio is 5.07%.